Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Indirubin derivative E804 inhibits angiogenesis

BMC Cancer201212:164

DOI: 10.1186/1471-2407-12-164

Received: 14 November 2011

Accepted: 3 May 2012

Published: 3 May 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
14 Nov 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
14 Jan 2012 Reviewed Reviewer Report - Abdel-Majid khatib
13 Feb 2012 Reviewed Reviewer Report - Martin Hagedorn
17 Mar 2012 Author responded Author comments - Jin-Kyung Kim
Resubmission - Version 3
17 Mar 2012 Submitted Manuscript version 3
30 Mar 2012 Reviewed Reviewer Report - Abdel-Majid khatib
4 Apr 2012 Reviewed Reviewer Report - Martin Hagedorn
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
3 May 2012 Editorially accepted
3 May 2012 Article published 10.1186/1471-2407-12-164

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Center for Efficacy Assessment and Development of Functional Foods and Drugs, Hallym University
(2)
Department of Biomedical Science, Catholic University of Daegu

Advertisement